The U.S. Food and Drug Administration (FDA) Wednesday accredited a crucial ingredient in plant-based burger patties made by Impossible Foods, a competitor to Beyond Meat, clearing the way for direct-to-consumer sales at U.S. grocery retailers.
The FDA in a statement stated it concluded soy leghemoglobin, a protein-based color additive Impossible Food makes use of to make its burgers look and “bleed” like real meat, was safe. It added that it plans to launch its Impossible Burger in select retail stores by September.
Objections to the FDA approval can be filed for 30 days, after which the direct sale of the beef imitation patties utilizing soy leghemoglobin is approved.
The Redwood City, California-based firm, established in 2016, is already selling its burger at some 10,000 fast-food restaurants across America, Hong Kong, and Singapore.
In America, it has collaborated with Burger King, which will soon sell the “Impossible Whopper” in its outlets nationwide. The Impossible Burger is also sold at fast foods chains Qdoba, White Castle, and Red Robin and Disney theme parks.
Impossible Foods could sell the cooked burgers to customers in restaurants; however, needed FDA approval to sell the patties in their uncooked form
Plant-based meat options have seen booming interest from customers and restaurants as customers want to add more plant-based protein to their food regimen, amid rising issues about health risks from consuming meat and the environmental hazards of intensive animal husbanding.
Beyond Meat, another California-based meat option that sells its plant-based sausages and burgers at restaurants and in supermarkets went public in May and has seen its shares soar over 780% since.